| Trial ID: | L1228 |
| Source ID: | NCT00122018
|
| Associated Drug: |
N-Acetylcysteine
|
| Title: |
An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents for Cardiac Surgery
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Kidney Failure, Acute|Kidney Failure, Chronic|Cardiac Surgical Procedures
|
| Interventions: |
DRUG: N-acetylcysteine|DRUG: fenoldopam
|
| Outcome Measures: |
Primary: Length of post-operative hospital stay, 30-day|Length of post-operative critical care stay, 30-day|Creatinine clearance post-operative days 3, 14, and nadir, 14 day | Secondary: Days to post-operative creatinine clearance nadir, 14 day|Intraoperative and post-operative pressor use (pressor-hours), 48 hour|Hospital costs, 30-day|Mortality, 30-day
|
| Sponsor/Collaborators: |
Sponsor: Linda F. Barr, M.D. | Collaborators: Abbott
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
80
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: DOUBLE|Primary Purpose: PREVENTION
|
| Start Date: |
2002-05
|
| Completion Date: |
2006-03
|
| Results First Posted: |
|
| Last Update Posted: |
2014-11-07
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00122018
|
